Posted:
#1
buying after the drop on earnings yesterday after the close..
I've traded this and had stock and call options in January when it last jumped, did quite well with it.
with that said, i just:
Great story here, simple problem: not growing at the rate investors believe it should, yet they posted 50% Y-O-Y....despite this, they have great leadership AND it's back to pre-Roche investment levels (Roche bought in for $1 Billion at $50 share in January, $780M on market, and $250 direct placement)
bought 500 shares at $22.50
and
sold 5 puts for $1 at 22.50 for Aug expiration.
Precision medicine, genetic screening for cancer patients.
Great story here, simple problem: not growing at the rate investors believe it should, yet they posted 50% Y-O-Y....despite this, they have great leadership AND it's back to pre-Roche investment levels (Roche bought in for $1 Billion at $50 share in January, $780M on market, and $250 direct placement)
With Roche as partner AND Google Ventures having invested $500M+ they have great partners and no doubt it will appreciate greatly in time. They'll get the reimbursements by insurance companies at some point.
Also,. they do have competition, however, their test is by far the most comprehensive and I feel they are the market leader.
Cheers,
Hot Forum Topics
